Maryland Could Receive Over $90 Million in Purdue Pharma Opioid Settlement

Maryland communities may soon see a substantial financial boost to combat the opioid crisis, as Attorney General Anthony Brown has joined all 54 of his counterparts across U.S. states and territories in a preliminary agreement to settle with Purdue Pharma and the Sackler family. The proposed settlement, which is still subject to final court approval, could total up to $7.4 billion nationwide.

This agreement aims to resolve years of litigation holding Purdue Pharma and its owners accountable for their role in fueling the opioid epidemic. The Sackler family has indicated its intention to move forward with the terms, which would provide funds for addiction treatment and recovery efforts across the country. In Maryland, local jurisdictions will be asked to formally sign on to the deal, a key step that will determine the exact payout the state receives.

Though the final amount is still undetermined, early estimates suggest Maryland could receive more than $90 million. These funds would be directed toward initiatives such as expanding treatment facilities, supporting recovery services, and preventing future addiction cases—a critical lifeline in a state that has seen thousands of opioid-related deaths.

The agreement comes amid broader national efforts to address the opioid epidemic’s devastating toll on public health and local economies. The outcome of the settlement could shape future litigation strategies and funding availability for affected communities. Residents are advised to follow developments closely, especially as local governments weigh their participation in the final court-approved agreement.

Article by multiple contributors, based upon information from a press release issued by the Maryland Office of the Attorney General

---